Dezenfeksiyon: Temel İlkelerden Geleceğin Teknolojilerine

McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12(1):147–179. doi:10.1128/CMR.12.1.147.

Rutala WA, Weber DJ. Disinfection, sterilization, and antisepsis: an overview. Am J Infect Control. 2019;47(Suppl)–A9. doi:10.1016/j.ajic.2019.01.018.

Otter JA, Yezli S, French GL. The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol. 2011;32(7):687–699. doi:10.1086/660363.

Rutala WA, Weber DJ; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008. Updated 2019. Atlanta, GA: Centers for Disease Control and Prevention; 2019.

Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis. 2002;8(9):881–890. doi:10.3201/eid0809.020063.

Paul S, Salunkhe S, Sravanthi K, Mane SV. Pioneering hand hygiene: Ignaz Semmelweis and the fight against puerperal fever. Cureus. 2024;16(10). doi:10.7759/cureus.71689.

Michaleas SN, Laios K, Charalabopoulos A, Samonis G, Karamanou M. Joseph Lister (1827–1912): a pioneer of antiseptic surgery. Cureus. 2022;14(12). doi:10.7759/cureus.32777.

Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control. 2010;38(5 Suppl 1)–S33. doi:10.1016/j.ajic.2010.04.196.

World Health Organization. Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level. Geneva: World Health Organization; 2016.

European Committee for Standardization. Chemical Disinfectants and Antiseptics—Application of European Standards for Chemical Disinfectants and Antiseptics (EN 14885). Brussels: European Committee for Standardization; 2018.

McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12(1):147–179. doi:10.1128/CMR.12.1.147.

Russell AD. Bacterial resistance to disinfectants: present knowledge and future problems. J Hosp Infect. 1999;43(Suppl)–S68. doi:10.1016/S0195-6701(99)90066-X.

Nikaido H. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother. 1989;33(11):1831–1836. doi:10.1128/AAC.33.11.1831.

Silhavy TJ, Kahne D, Walker S. The bacterial cell envelope. Cold Spring Harb Perspect Biol. 2010;2(5). doi:10.1101/cshperspect.a000414.

Krewing M, Mönch E, Bolten A, Niesalla H. Resistance or tolerance? Highlighting the need for precise terminology in the field of disinfection. J Hosp Infect. 2024;150:51–60. doi:10.1016/j.jhin.2024.05.006.

Chapman JS. Disinfectant resistance mechanisms, cross-resistance, and co-resistance. Int Biodeterior Biodegradation. 2003;51(4):271–276. doi:10.1016/S0964-8305(03)00044-1.

Poole K. Efflux-mediated antimicrobial resistance. J Antimicrob Chemother. 2005;56(1):20–51. doi:10.1093/jac/dki171.

Denyer SP, Maillard JY. Cellular impermeability and uptake of biocides and antibiotics in Gram-negative bacteria. J Appl Microbiol. 2002;92(Suppl):35S–45S. doi:10.1046/j.1365-2672.92.5s1.19.x.

Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006;6:130. doi:10.1186/1471-2334-6-130.

Setlow P. Spores of Bacillus subtilis: their resistance to and killing by radiation, heat and chemicals. J Appl Microbiol. 2006;101(3):514–525. doi:10.1111/j.1365-2672.2005.02736.x.

Leggett MJ, McDonnell G, Denyer SP, Setlow P, Maillard JY. Bacterial spore structures and their protective role in biocide resistance. J Appl Microbiol. 2012;113(3):485–498. doi:10.1111/j.1365-2672.2012.05336.x.

Rutala WA, Weber DJ. Disinfection, sterilization, and antisepsis: an overview. Am J Infect Control. 2019;47(Suppl)–A9. doi:10.1016/j.ajic.2019.01.018.

Weber DJ, Anderson DJ, Sexton DJ, Rutala WA. Role of the environment in the transmission of Clostridium difficile in health care facilities. Am J Infect Control. 2013;41(5 Suppl)–S110. doi:10.1016/j.ajic.2012.12.009.

Brennan PJ, Nikaido H. The envelope of mycobacteria. Annu Rev Biochem. 1995;64:29–63. doi:10.1146/annurev.bi.64.070195.000333.

McDonnell G. Antisepsis, Disinfection, and Sterilization: Types, Action, and Resistance. Washington, DC: ASM Press; 2007.

Best M, Sattar SA, Springthorpe VS, Kennedy ME. Efficacies of selected disinfectants against Mycobacterium tuberculosis. J Clin Microbiol. 1990;28(10):2234–2239. doi:10.1128/JCM.28.10.2234-2239.1990.

Rutala WA, Weber DJ; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008. Updated May 2019. Atlanta, GA: Centers for Disease Control and Prevention; 2019.

Kampf G. Efficacy of ethanol against viruses in hand disinfection. J Hosp Infect. 2018;98(4):331–338. doi:10.1016/j.jhin.2017.08.025.

Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246–251. doi:10.1016/j.jhin.2020.01.022.

Hall AJ, Vinjé J, Lopman B, et al. Updated norovirus outbreak management and disease prevention guidelines. MMWR Recomm Rep. 2011;60(RR-03):1–18.

Darnell MER, Subbarao K, Feinstone SM, Taylor DR. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virol Methods. 2004;121(1):85–91. doi:10.1016/j.jviromet.2004.06.006.

Gow NAR, Hube B. Importance of the Candida albicans cell wall during commensalism and infection. Curr Opin Microbiol. 2012;15(4):406–412. doi:10.1016/j.mib.2012.04.005.

Jeffery-Smith A, Taori SK, Schelenz S, et al. Candida auris: a review of the literature. Clin Microbiol Rev. 2018;31(1). doi:10.1128/CMR.00029-17.

Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999;12(2):310–350. doi:10.1128/CMR.12.2.310.

Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8(9):623–633. doi:10.1038/nrmicro2415.

Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167–193. doi:10.1128/CMR.15.2.167-193.2002.

Donlan RM. Biofilms and device-associated infections. Emerg Infect Dis. 2001;7(2):277–281. doi:10.3201/eid0702.010226.

Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2(2):95–108. doi:10.1038/nrmicro821.

Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318–1322. doi:10.1126/science.284.5418.1318.

Russell AD. Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations. Lancet Infect Dis. 2003;3(12):794–803. doi:10.1016/S1473-3099(03)00833-8.

Maillard JY. Bacterial resistance to biocides in the healthcare environment: should it be of genuine concern? J Hosp Infect. 2007;65(Suppl 2):60–72. doi:10.1016/S0195-6701(07)60018-8.

European Committee for Standardization. EN 13727:2012+A2:2015. Chemical disinfectants and antiseptics—Quantitative suspension test for the evaluation of bactericidal activity in the medical area—Test method and requirements (phase 2, step 1). Brussels: CEN; 2015.

European Committee for Standardization. EN 13624:2021. Chemical disinfectants and antiseptics—Quantitative suspension test for the evaluation of fungicidal or yeasticidal activity in the medical area—Test method and requirements (phase 2, step 1). Brussels: CEN; 2021.

European Committee for Standardization. EN 14476:2013+A2:2019. Chemical disinfectants and antiseptics—Quantitative suspension test for the evaluation of virucidal activity in the medical area—Test method and requirements (phase 2, step 1). Brussels: CEN; 2019.

European Committee for Standardization. EN 17126:2018. Chemical disinfectants and antiseptics—Quantitative suspension test for the evaluation of sporicidal activity of chemical disinfectants in the medical area—Test method and requirements (phase 2, step 1). Brussels: CEN; 2018.

Kampf G. Biocidal agents used for disinfection can enhance antibiotic resistance in Gram-negative species. Antibiotics (Basel). 2018;7(4):110. doi:10.3390/antibiotics7040110.

Wales AD, Davies RH. Co-selection of resistance to antibiotics, biocides and heavy metals, and its relevance to foodborne pathogens. Antibiotics (Basel). 2015;4(4):567–604. doi:10.3390/antibiotics4040567.

Kampf G. Acquired resistance to chlorhexidine—is it time to establish an “antiseptic stewardship” initiative? J Hosp Infect. 2016;94(3):213–227. doi:10.1016/j.jhin.2016.08.018.

McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12(1):147–179. doi:10.1128/CMR.12.1.147.

Kampf G, Kramer A. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev. 2004;17(4):863–893. doi:10.1128/CMR.17.4.863-893.2004.

Kampf G. Efficacy of ethanol against viruses in hand disinfection. J Hosp Infect. 2018;98(4):331–338. doi:10.1016/j.jhin.2017.08.025.

World Health Organization. WHO Guidelines on Hand Hygiene in Health Care. Geneva: World Health Organization; 2009.

Boyce JM, Pittet D. Guideline for hand hygiene in health-care settings. MMWR Recomm Rep. 2002;51(RR-16):1–45.

Rutala WA, Weber DJ. Disinfection, sterilization, and antisepsis: an overview. Am J Infect Control. 2019;47(Suppl)–A9. doi:10.1016/j.ajic.2019.01.018.

Rutala WA, Weber DJ. Uses of inorganic hypochlorite (bleach) in health-care facilities. Clin Microbiol Rev. 1997;10(4):597–610. doi:10.1128/CMR.10.4.597.

Block SS, ed. Disinfection, Sterilization, and Preservation. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2001.

Donskey CJ. Does improving surface cleaning and disinfection reduce health care-associated infections? Am J Infect Control. 2013;41(5 Suppl)–S19. doi:10.1016/j.ajic.2012.12.010.

Finnegan M, Linley E, Denyer SP, McDonnell G, Simons C, Maillard JY. Mode of action of hydrogen peroxide and other oxidizing agents: differences between liquid and gas forms. J Antimicrob Chemother. 2010;65(10):2108–2115. doi:10.1093/jac/dkq308.

Linley E, Denyer SP, McDonnell G, Simons C, Maillard JY. Use of hydrogen peroxide as a biocide: new consideration of its mechanisms of biocidal action. J Antimicrob Chemother. 2012;67(7):1589–1596. doi:10.1093/jac/dks129.

Kitis M. Disinfection of wastewater with peracetic acid: a review. Environ Int. 2004;30(1):47–55. doi:10.1016/S0160-4120(03)00147-8.

Rutala WA, Weber DJ. Sterilization, high-level disinfection, and environmental cleaning. Infect Dis Clin North Am. 2011;25(1):45–76. doi:10.1016/j.idc.2010.11.009.

McDonnell G. Antisepsis, Disinfection, and Sterilization: Types, Action, and Resistance. Washington, DC: ASM Press; 2007.

Rutala WA, Weber DJ; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008. Updated 2019. Atlanta, GA: Centers for Disease Control and Prevention; 2019.

Kovaleva J, Peters FTM, van der Mei HC, Degener JE. Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy. Clin Microbiol Rev. 2013;26(2):231–254. doi:10.1128/CMR.00085-12.

Jennings MC, Minbiole KPC, Wuest WM. Quaternary ammonium compounds: an antimicrobial mainstay and platform for innovation. ACS Infect Dis. 2015;1(7):288–303. doi:10.1021/acsinfecdis.5b00047.

European Committee for Standardization. EN 13727:2012+A2:2015. Chemical disinfectants and antiseptics—Quantitative suspension test for the evaluation of bactericidal activity in the medical area—Test method and requirements (phase 2, step 1). Brussels: CEN; 2015.

European Committee for Standardization. EN 13624:2021. Chemical disinfectants and antiseptics—Quantitative suspension test for the evaluation of fungicidal or yeasticidal activity in the medical area—Test method and requirements (phase 2, step 1). Brussels: CEN; 2021.

European Committee for Standardization. EN 14476:2025. Chemical disinfectants and antiseptics—Quantitative suspension test for the evaluation of virucidal activity in the medical area—Test method and requirements (phase 2, step 1). Brussels: CEN; 2025.

European Committee for Standardization. EN 17126:2018. Chemical disinfectants and antiseptics—Quantitative suspension test for the evaluation of sporicidal activity of chemical disinfectants in the medical area—Test method and requirements (phase 2, step 1). Brussels: CEN; 2018.

Gerba CP. Quaternary ammonium biocides: efficacy in application. Appl Environ Microbiol. 2015;81(2):464–469. doi:10.1128/AEM.02633-14.

Buffet-Bataillon S, Tattevin P, Bonnaure-Mallet M, Jolivet-Gougeon A. Emergence of resistance to antibacterial agents: the role of quaternary ammonium compounds. Int J Antimicrob Agents. 2012;39(5):381–389. doi:10.1016/j.ijantimicag.2012.01.011.

McBain AJ, Ledder RG, Moore LE, Catrenich CE, Gilbert P. Effects of quaternary-ammonium-based formulations on bacterial community dynamics and antimicrobial susceptibility. Appl Environ Microbiol. 2004;70(6):3449–3456. doi:10.1128/AEM.70.6.3449-3456.2004.

Webber MA, Randall LP, Cooles S, Woodward MJ, Piddock LJV. Triclosan resistance in Salmonella enterica serovar Typhimurium. J Antimicrob Chemother. 2008;62(1):83–91. doi:10.1093/jac/dkn137.

Russell AD. Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations. Lancet Infect Dis. 2003;3(12):794–803. doi:10.1016/S1473-3099(03)00833-8.

Denyer SP, Stewart GSAB. Mechanisms of action of disinfectants. Int Biodeterior Biodegradation. 1998;41(3–4):261–268. doi:10.1016/S0964-8305(98)00023-7.

Gottardi W. Iodine and iodine compounds. In: Block SS, ed. Disinfection, Sterilization, and Preservation. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2001.

Bigliardi PL, Alsagoff SAL, El-Kafrawi HY, et al. Povidone iodine in wound healing: a review of current concepts and practices. Int J Surg. 2017;44:260–268. doi:10.1016/j.ijsu.2017.06.073.

Milstone AM, Passaretti CL, Perl TM. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis. 2008;46(2):274–281. doi:10.1086/524736.

O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9)–e193. doi:10.1093/cid/cir257.

Kampf G. Acquired resistance to chlorhexidine—is it time to establish an “antiseptic stewardship” initiative? J Hosp Infect. 2016;94(3):213–227. doi:10.1016/j.jhin.2016.08.018.

Maillard JY. Resistance of bacteria to biocides. Microbiol Spectr. 2018;6(2). doi:10.1128/microbiolspec.ARBA-0006-2017.

Bridier A, Briandet R, Thomas V, Dubois-Brissonnet F. Resistance of bacterial biofilms to disinfectants: a review. Biofouling. 2011;27(9):1017–1032. doi:10.1080/08927014.2011.626899.

Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1):76–83. doi:10.1016/j.biotechadv.2008.09.002.

Chen W, Yang H, Peng C, Wu T. Resolving the “health vs environment” dilemma with sustainable disinfection during the COVID-19 pandemic. Environ Sci Pollut Res Int. 2023;30(9):24737–24741. doi:10.1007/s11356-023-25167-6.

International Organization for Standardization. ISO 15883-1:2024. Washer-disinfectors—Part 1: General requirements, terms and definitions and tests. Geneva: ISO; 2024.

Weber DJ, Rutala WA. Understanding and preventing transmission of healthcare-associated pathogens due to the contaminated hospital environment. Infect Control Hosp Epidemiol. 2013;34(5):449–452. doi:10.1086/670223.

Dancer SJ. The role of environmental cleaning in the control of hospital-acquired infection. J Hosp Infect. 2009;73(4):378–385. doi:10.1016/j.jhin.2009.03.030.

Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006;6:130. doi:10.1186/1471-2334-6-130.

Rutala WA, Weber DJ. Monitoring and improving the effectiveness of surface cleaning and disinfection. Am J Infect Control. 2016;44(5 Suppl)–e76. doi:10.1016/j.ajic.2015.10.039.

Centers for Disease Control and Prevention (CDC). Guidelines for Environmental Infection Control in Health-Care Facilities. 2003; updated 2019. Atlanta, GA: CDC; 2019.

Spaulding EH. Chemical disinfection of medical and surgical materials. In: Lawrence CA, Block SS, eds. Disinfection, Sterilization and Preservation. Philadelphia: Lea & Febiger; 1968:517–531.

Rutala WA, Weber DJ. Disinfection and sterilization in health care facilities: an overview and current issues. Infect Dis Clin North Am. 2016;30(3):609–637. doi:10.1016/j.idc.2016.04.002.

McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12(1):147–179. doi:10.1128/CMR.12.1.147.

Alfa MJ. Monitoring and improving the effectiveness of cleaning medical and surgical devices. Am J Infect Control. 2013;41(5 Suppl)–S59. doi:10.1016/j.ajic.2012.12.006.

Otter JA, Yezli S, Salkeld JAG, French GL. Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. Am J Infect Control. 2013;41(5 Suppl)–S11. doi:10.1016/j.ajic.2012.12.004.

Carling PC, Huang SS. Improving healthcare environmental cleaning and disinfection: current and evolving issues. Infect Control Hosp Epidemiol. 2013;34(5):507–513. doi:10.1086/670222.

Boyce JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect. 2007;65(Suppl 2):50–54. doi:10.1016/S0195-6701(07)60015-2.

Anderson DJ, Chen LF, Weber DJ, et al. Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (BETR Disinfection): a cluster-randomised, multicentre, crossover study. Lancet. 2017;389(10071):805–814. doi:10.1016/S0140-6736(16)31588-4.

Kim YA. Roles of clinical microbiology in hospital environmental cleaning and disinfection: a narrative review. Ann Clin Microbiol. 2024;27(3):171–177. doi:10.5145/ACM.2024.27.3.3.

Vincent JL. Nosocomial infections in adult intensive-care units. Lancet. 2003;361(9374):2068–2077. doi:10.1016/S0140-6736(03)13644-6.

Allegranzi B, Pittet D. Role of hand hygiene in healthcare-associated infection prevention. J Hosp Infect. 2009;73(4):305–315. doi:10.1016/j.jhin.2009.04.019.

Munoz-Price LS, Weinstein RA. Acinetobacter infection. N Engl J Med. 2008;358(12):1271–1281. doi:10.1056/NEJMra070741.

Passaretti CL, Otter JA, Reich NG, et al. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis. 2013;56(1):27–35. doi:10.1093/cid/cis839.

Carling PC, Parry MF, Von Beheren SM. Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(1):1–7. doi:10.1086/524329.

ASGE Quality Assurance in Endoscopy Committee. Multisociety guideline on reprocessing flexible gastrointestinal endoscopes: 2016 update. Gastrointest Endosc. 2017;85(2):282–294.

Rutala WA, Weber DJ. Reprocessing semicritical items: current issues and new technologies. Am J Infect Control. 2016;44(5 Suppl)–e62. doi:10.1016/j.ajic.2015.12.029.

Kovaleva J, Peters FTM, van der Mei HC, Degener JE. Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy. Clin Microbiol Rev. 2013;26(2):231–254. doi:10.1128/CMR.00085-12.

Ofstead CL, Wetzler HP, Snyder AK, Horton RA. Endoscope reprocessing methods: a prospective study on the impact of human factors and automation. Gastroenterol Nurs. 2010;33(4):304–311. doi:10.1097/SGA.0b013e3181e9431a.

Dancer SJ. Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev. 2014;27(4):665–690. doi:10.1128/CMR.00020-14.

Rutala WA, Weber DJ; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008. Updated 2019. Atlanta, GA: Centers for Disease Control and Prevention; 2019.

Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control. 2010;38(5 Suppl 1)–S33. doi:10.1016/j.ajic.2010.04.196.

Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246–251. doi:10.1016/j.jhin.2020.01.022.

Rutala WA, Weber DJ. Best practices for disinfection of noncritical environmental surfaces and equipment in health care facilities. Am J Infect Control. 2019;47(Suppl)–A105. doi:10.1016/j.ajic.2019.01.014.

Boyce JM. Modern technologies for improving cleaning and disinfection of environmental surfaces in hospitals. Antimicrob Resist Infect Control. 2016;5:10. doi:10.1186/s13756-016-0111-x.

Guh A, Carling P; Centers for Disease Control and Prevention. Options for Evaluating Environmental Cleaning. Atlanta, GA: Centers for Disease Control and Prevention; 2010.

Jain S, Dempsey K, Clezy K, Mitchell BG, Kiernan MA. Sustainability and novel technologies to improve environmental cleaning in healthcare—implications and considerations. Infect Dis Health. 2025;30(1):74–78. doi:10.1016/j.idh.2024.07.002.

Anderson DJ, Gergen MF, Smathers E, et al. Decontamination of targeted pathogens from patient rooms using an automated ultraviolet-C-emitting device. Infect Control Hosp Epidemiol. 2013;34(5):466–471. doi:10.1086/670215.

Otter JA, Yezli S, Perl TM, Barbut F, French GL. Is there a role for “no-touch” automated room disinfection systems in infection prevention and control? J Hosp Infect. 2013;83(1):1–13. doi:10.1016/j.jhin.2012.10.002.

Weber DJ, Rutala WA, Anderson DJ, et al. Effectiveness of ultraviolet devices and hydrogen peroxide systems for terminal room decontamination: focus on clinical trials. Am J Infect Control. 2016;44(5 Suppl)–e84. doi:10.1016/j.ajic.2015.11.015.

Ke D, Tan X, Chen K, et al. Advances in novel disinfection technologies for biofilm-associated nosocomial infections. Sichuan Da Xue Xue Bao Yi Xue Ban. 2025;56(5):1243–1250. doi:10.12182/20250960203.

Gastaldi S, Accorgi D, D'Ancona F. Tools and strategies for monitoring hospital environmental hygiene services. J Hosp Infect. 2025;159:52–61. doi:10.1016/j.jhin.2025.01.011.

Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) study. JAMA. 1995;274(8):639–644. doi:10.1001/jama.1995.03530080055041.

Huslage K, Rutala WA, Sickbert-Bennett E, Weber DJ. A quantitative approach to defining “high-touch” surfaces in hospitals. Infect Control Hosp Epidemiol. 2010;31(8):850–853. doi:10.1086/655016.

Carling PC, Huang SS. Improving healthcare environmental cleaning and disinfection: current and evolving issues. Infect Control Hosp Epidemiol. 2013;34(5):507–513. doi:10.1086/670222.

Boyce JM. Modern technologies for improving cleaning and disinfection of environmental surfaces in hospitals. Antimicrob Resist Infect Control. 2016;5:10. doi:10.1186/s13756-016-0111-x.

Trautmann M, Lepper PM, Haller M. Ecology of Pseudomonas aeruginosa in the intensive care unit and the evolving role of water outlets as a reservoir of the organism. Am J Infect Control. 2005;33(5 Suppl 1)–S49. doi:10.1016/j.ajic.2005.03.006.

Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol. 1999;20(4):250–278. doi:10.1086/501620.

World Health Organization. Global Guidelines for the Prevention of Surgical Site Infection. 2nd ed. Geneva: World Health Organization; 2018.

Anderson DJ, Podgorny K, Berríos-Torres SI, et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(6):605–627. doi:10.1086/676022.

Dharan S, Pittet D. Environmental controls in operating theatres. J Hosp Infect. 2002;51(2):79–84. doi:10.1053/jhin.2002.1217.

Carling PC, Briggs JL, Perkins J, Highlander D. Improved cleaning of patient rooms using a new targeting method. Clin Infect Dis. 2006;42(3):385–388. doi:10.1086/499361.

World Health Organization. Laboratory Biosafety Manual. 4th ed. Geneva: World Health Organization; 2020.

Centers for Disease Control and Prevention, National Institutes of Health. Biosafety in Microbiological and Biomedical Laboratories (BMBL). 6th ed. Atlanta, GA: CDC/NIH; 2020.

Sehulster L, Chinn RYW; CDC; HICPAC. Guidelines for environmental infection control in health-care facilities. MMWR Recomm Rep. 2003;52(RR-10):1–42.

Occupational Safety and Health Administration (OSHA). Occupational Exposure to Bloodborne Pathogens; Standard (29 CFR 1910.1030). Washington, DC: OSHA; 1991, as amended.

United States Pharmacopeia. USP General Chapter <797>: Pharmaceutical Compounding—Sterile Preparations. Rockville, MD: United States Pharmacopeia; 2023.

International Organization for Standardization. ISO 14644-1:2015. Cleanrooms and Associated Controlled Environments—Part 1: Classification of Air Cleanliness by Particle Concentration. Geneva: ISO; 2015.

United States Pharmacopeia. USP General Chapter <800>: Hazardous Drugs—Handling in Healthcare Settings. Rockville, MD: United States Pharmacopeia; 2023.

Sandle T. Cleanroom and microbiological environmental monitoring in pharmaceutical and healthcare settings. In: Pharmaceutical Microbiology: Essentials for Quality Assurance and Quality Control. Cambridge: Woodhead Publishing; 2016.

Centers for Disease Control and Prevention; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for Environmental Infection Control in Health-Care Facilities. 2003; updated 2019. Atlanta, GA: CDC; 2019.

Siegel JD, Rhinehart E, Jackson M, Chiarello L; HICPAC. Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Atlanta, GA: Centers for Disease Control and Prevention; 2007.

Boyce JM. Hand and environmental hygiene: respective roles for MRSA, multi-resistant Gram-negatives, Clostridioides difficile, and Candida spp. Antimicrob Resist Infect Control. 2024;13(1):110. doi:10.1186/s13756-024-01461-x.

Gastaldi S, Accorgi D, D'Ancona F. Tools and strategies for monitoring hospital environmental hygiene services. J Hosp Infect. 2025;159:52–61. doi:10.1016/j.jhin.2025.01.011.

Anderson DJ, Gergen MF, Smathers E, et al. Decontamination of targeted pathogens from patient rooms using an automated ultraviolet-C-emitting device. Infect Control Hosp Epidemiol. 2013;34(5):466–471. doi:10.1086/670215.

Mehta I, Hsueh HY, Taghipour S, Li W, Saeedi S. UV disinfection robots: a review. Rob Auton Syst. 2023;161:104332. doi:10.1016/j.robot.2022.104332.

World Health Organization. Global Action Plan on Antimicrobial Resistance. Geneva: World Health Organization; 2015.

McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12(1):147–179. doi:10.1128/CMR.12.1.147.

Kampf G. Acquired resistance to chlorhexidine—is it time to establish an “antiseptic stewardship” initiative? J Hosp Infect. 2016;94(3):213–227. doi:10.1016/j.jhin.2016.08.018.

Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x.

Weber DJ, Rutala WA. Understanding and preventing transmission of healthcare-associated pathogens due to the contaminated hospital environment. Infect Control Hosp Epidemiol. 2013;34(5):449–452. doi:10.1086/670223.

Maillard JY, Pascoe M. Disinfectants and antiseptics: mechanisms of action and resistance. Nat Rev Microbiol. 2024;22(1):4–17. doi:10.1038/s41579-023-00958-3.

Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15(2):167–193. doi:10.1128/CMR.15.2.167-193.2002.

Buffet-Bataillon S, Tattevin P, Bonnaure-Mallet M, Jolivet-Gougeon A. Emergence of resistance to antibacterial agents: the role of quaternary ammonium compounds. Int J Antimicrob Agents. 2012;39(5):381–389. doi:10.1016/j.ijantimicag.2012.01.011.

Bridier A, Briandet R, Thomas V, Dubois-Brissonnet F. Resistance of bacterial biofilms to disinfectants: a review. Biofouling. 2011;27(9):1017–1032. doi:10.1080/08927014.2011.626899.

Wales AD, Davies RH. Co-selection of resistance to antibiotics, biocides and heavy metals, and its relevance to foodborne pathogens. Antibiotics (Basel). 2015;4(4):567–604. doi:10.3390/antibiotics4040567.

Kampf G. Antibiotic resistance can be enhanced in Gram-positive species by some biocidal agents used for disinfection. Antibiotics (Basel). 2019;8(1):13. doi:10.3390/antibiotics8010013.

Otter JA, Yezli S, Salkeld JAG, French GL. Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. Am J Infect Control. 2013;41(5 Suppl)–S11. doi:10.1016/j.ajic.2012.12.004.

Wendt C, Dietze B, Dietz E, Rüden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol. 1997;35(6):1394–1397. doi:10.1128/JCM.35.6.1394-1397.1997.

Hayden MK, Bonten MJM, Blom DW, et al. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis. 2006;42(11):1552–1560. doi:10.1086/503845.

Centers for Disease Control and Prevention. Facility Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE). Atlanta, GA: CDC; 2015.

Carling PC, Parry MF, Von Beheren SM. Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(1):1–7. doi:10.1086/524329.

Weber DJ, Rutala WA, Anderson DJ, Chen LF, Sickbert-Bennett EE, Boyce JM. Effectiveness of ultraviolet devices and hydrogen peroxide systems for terminal room decontamination: focus on clinical trials. Am J Infect Control. 2016;44(5 Suppl)–e84. doi:10.1016/j.ajic.2015.11.015.

Dancer SJ. Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev. 2014;27(4):665–690. doi:10.1128/CMR.00020-14.

Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Atlanta, GA: Centers for Disease Control and Prevention; 2007.

World Health Organization. Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level. Geneva: World Health Organization; 2016.

Allegranzi B, Pittet D. Role of hand hygiene in healthcare-associated infection prevention. J Hosp Infect. 2009;73(4):305–315. doi:10.1016/j.jhin.2009.04.019.

Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Assessment of the Antibiotic Resistance Effects of Biocides. Brussels: European Commission; 2009.

Valencia-Shelton F, Anderson N, Palavecino EL, Navas ME, Larkin PMK, She R, Filkins LM. Approaches to developing and implementing a molecular diagnostics stewardship program for infectious diseases: an ASM Laboratory Practices Subcommittee report. J Clin Microbiol. 2024;62(11). doi:10.1128/jcm.00941-24.

Barlam TF, Cosgrove SE, Abbo LM, et al. Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10)–e77. doi:10.1093/cid/ciw118.

Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44(2):159–177. doi:10.1086/510393.

Baur D, Gladstone BP, Burkert F, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(9):990–1001. doi:10.1016/S1473-3099(17)30325-0.

Carling PC. Methods for assessing the adequacy of practice and improving room disinfection. Am J Infect Control. 2013;41(5 Suppl)–S25. doi:10.1016/j.ajic.2013.01.003.

Ward DJ. The role of education in the prevention and control of infection: a review of the literature. Nurse Educ Today. 2011;31(1):9–17. doi:10.1016/j.nedt.2010.03.007.

El Arab RA, Almoosa Z, Alkhunaizi M, Abuadas FH, Somerville J. Artificial intelligence in hospital infection prevention: an integrative review. Front Public Health. 2025;13:1547450. doi:10.3389/fpubh.2025.1547450.

Bassetti M, Vena A, Croxatto A, Righi E, Guery B. How to manage Pseudomonas aeruginosa infections. Drugs Context. 2018;7:212527. doi:10.7573/dic.212527

Rutala WA, Weber DJ. Disinfection, sterilization, and antisepsis: an overview. Am J Infect Control. 2019;47(Suppl)–A9. doi:10.1016/j.ajic.2019.01.018.

Carling PC, Huang SS. Improving healthcare environmental cleaning and disinfection: current and evolving issues. Infect Control Hosp Epidemiol. 2013;34(5):507–513. doi:10.1086/670222.

McDonnell G. Antisepsis, Disinfection, and Sterilization: Types, Action, and Resistance. 2nd ed. Washington, DC: ASM Press; 2017.

Carling PC, Parry MF, Von Beheren SM. Identifying opportunities to enhance environmental cleaning in 23 acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(1):1–7. doi:10.1086/524329.

Weber DJ, Rutala WA. Understanding and preventing transmission of healthcare-associated pathogens due to the contaminated hospital environment. Infect Control Hosp Epidemiol. 2013;34(5):449–452. doi:10.1086/670223.

World Health Organization. Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level. Geneva: World Health Organization; 2016.

European Committee for Standardization. EN 14885:2022. Chemical disinfectants and antiseptics—Application of European Standards for chemical disinfectants and antiseptics. Brussels: CEN; 2022.

Sehulster L, Chinn RYW; CDC; HICPAC. Guidelines for environmental infection control in health-care facilities. MMWR Recomm Rep. 2003;52(RR-10):1–42.

European Committee for Standardization. EN 13727:2012+A2:2015. Chemical disinfectants and antiseptics—Quantitative suspension test for the evaluation of bactericidal activity in the medical area—Test method and requirements (phase 2, step 1). Brussels: CEN; 2015.

European Committee for Standardization. EN 13697:2023. Chemical disinfectants and antiseptics—Quantitative non-porous surface test for the evaluation of bactericidal and yeasticidal and/or fungicidal activity of chemical disinfectants used in food, industrial, domestic and institutional areas without mechanical action—Test method and requirements (phase 2, step 2). Brussels: CEN; 2023.

International Organization for Standardization. ISO 14644-1:2015. Cleanrooms and associated controlled environments—Part 1: Classification of air cleanliness by particle concentration. Geneva: ISO; 2015.

United States Pharmacopeia. USP General Chapter <797>: Pharmaceutical Compounding—Sterile Preparations. Rockville, MD: United States Pharmacopeia; 2023.

U.S. Food and Drug Administration. Guidance for Industry and FDA Staff: Content and Format of Premarket Notification [510(k)] Submissions for Liquid Chemical Sterilants/High Level Disinfectants. Rockville, MD: FDA; 2000.

Association for the Advancement of Medical Instrumentation. ANSI/AAMI ST58:2024. Chemical Sterilization and High-Level Disinfection in Health Care Facilities. Arlington, VA: AAMI; 2024.

European Committee for Standardization. EN 14476:2025. Chemical disinfectants and antiseptics—Quantitative suspension test for the evaluation of virucidal activity in the medical area—Test method and requirements (phase 2, step 1). Brussels: CEN; 2025.

European Committee for Standardization. EN 17126:2018. Chemical disinfectants and antiseptics—Quantitative suspension test for the evaluation of sporicidal activity of chemical disinfectants in the medical area—Test method and requirements (phase 2, step 1). Brussels: CEN; 2018.

European Committee for Standardization. EN 16615:2026. Chemical disinfectants and antiseptics—Quantitative test method for the evaluation of bactericidal, yeasticidal and/or fungicidal and/or tuberculocidal and/or mycobactericidal activity on non-porous surfaces with mechanical action employing wipes or mops in the medical area (4-field test)—Test method and requirements (phase 2, step 2). Brussels: CEN; 2026.

European Committee for Standardization. EN 1500:2013. Chemical disinfectants and antiseptics—Hygienic handrub—Test method and requirements (phase 2, step 2). Brussels: CEN; 2013.

European Committee for Standardization. EN 12791:2016+A1:2017. Chemical disinfectants and antiseptics—Surgical hand disinfection—Test method and requirements (phase 2, step 2). Brussels: CEN; 2017.

Türk Standardları Enstitüsü. TS EN 14885:2022. Kimyasal dezenfektanlar ve antiseptikler—Kimyasal dezenfektanlar ve antiseptikler için Avrupa standartlarının uygulanması. Ankara: TSE; 2022.

Türk Standardları Enstitüsü. TS EN ISO 14644-1:2016. Temiz odalar ve ilgili kontrollü ortamlar—Bölüm 1: Parçacık konsantrasyonuna göre hava temizliğinin sınıflandırılması. Ankara: TSE; 2016.

Occupational Safety and Health Administration. Air Contaminants—Permissible Exposure Limits (29 CFR 1910.1000); Ethylene Oxide (29 CFR 1910.1047); Formaldehyde (29 CFR 1910.1048). Washington, DC: U.S. Department of Labor.

American Conference of Governmental Industrial Hygienists. TLVs and BEIs: Threshold Limit Values for Chemical Substances and Physical Agents and Biological Exposure Indices. Cincinnati, OH: ACGIH; 2010.

Dancer SJ. The role of environmental cleaning in the control of hospital-acquired infection. J Hosp Infect. 2009;73(4):378–385. doi:10.1016/j.jhin.2009.03.030.

Ivers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;(6). doi:10.1002/14651858.CD000259.pub3.

Han JH, Sullivan N, Leas BF, Pegues DA, Kaczmarek JL, Umscheid CA. Cleaning hospital room surfaces to prevent health care-associated infections: a technical brief. Ann Intern Med. 2015;163(8):598–607. doi:10.7326/M15-1192.

Russell AD. Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations. Lancet Infect Dis. 2003;3(12):794–803. doi:10.1016/S1473-3099(03)00833-8.

World Health Organization. Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level. Geneva: World Health Organization; 2016.

World Health Organization. Safe Management of Wastes from Health-care Activities. 2nd ed. Geneva: World Health Organization; 2014.

McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999;12(1):147–179. doi:10.1128/CMR.12.1.147.

Rutala WA, Weber DJ. Disinfection and sterilization in health care facilities: an overview and current issues. Infect Dis Clin North Am. 2016;30(3):609–637. doi:10.1016/j.idc.2016.04.002.

Allegranzi B, Pittet D. Role of hand hygiene in healthcare-associated infection prevention. J Hosp Infect. 2009;73(4):305–315. doi:10.1016/j.jhin.2009.04.019.

Larson E. A causal link between handwashing and risk of infection? Examination of the evidence. Infect Control Hosp Epidemiol. 1988;9(1):28–36. doi:10.1086/645729.

Otter JA, Yezli S, Salkeld JAG, French GL. Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. Am J Infect Control. 2013;41(5 Suppl)–S11. doi:10.1016/j.ajic.2012.12.004.

Dyar OJ, Huttner B, Schouten J, Pulcini C. What is antimicrobial stewardship? Clin Microbiol Infect. 2017;23(11):793–798. doi:10.1016/j.cmi.2017.08.026.

Rutala WA, Weber DJ; Healthcare Infection Control Practices Advisory Committee (HICPAC). Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008. Updated 2019. Atlanta, GA: Centers for Disease Control and Prevention; 2019.

Boyce JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect. 2007;65(Suppl 2):50–54. doi:10.1016/S0195-6701(07)60015-2.

Kümmerer K. Significance of antibiotics in the environment. J Antimicrob Chemother. 2003;52(1):5–7. doi:10.1093/jac/dkg293.

Wales AD, Davies RH. Co-selection of resistance to antibiotics, biocides and heavy metals, and its relevance to foodborne pathogens. Antibiotics (Basel). 2015;4(4):567–604. doi:10.3390/antibiotics4040567.

Buffet-Bataillon S, Tattevin P, Bonnaure-Mallet M, Jolivet-Gougeon A. Emergence of resistance to antibacterial agents: the role of quaternary ammonium compounds. Int J Antimicrob Agents. 2012;39(5):381–389. doi:10.1016/j.ijantimicag.2012.01.011.

Poole K. Mechanisms of bacterial biocide and antibiotic resistance. J Appl Microbiol. 2002;92(Suppl):55S–64S.

Martínez-Carballo E, González-Barreiro C, Sitka A, Scharf S, Gans O. Determination of selected quaternary ammonium compounds by liquid chromatography with mass spectrometry. Environ Pollut. 2007;145(2):489–496.

McBain AJ, Ledder RG, Moore LE, Catrenich CE, Gilbert P. Effects of quaternary-ammonium-based formulations on bacterial community dynamics and antimicrobial susceptibility. Appl Environ Microbiol. 2004;70(6):3449–3456. doi:10.1128/AEM.70.6.3449-3456.2004.

Kampf G. Acquired resistance to chlorhexidine—is it time to establish an “antiseptic stewardship” initiative? J Hosp Infect. 2016;94(3):213–227. doi:10.1016/j.jhin.2016.08.018.

Krewing M, Mönch E, Bolten A, Niesalla H. Resistance or tolerance? Highlighting the need for precise terminology in the field of disinfection. J Hosp Infect. 2024;150:51–60. doi:10.1016/j.jhin.2024.05.006.

El Arab RA, Almoosa Z, Alkhunaizi M, Abuadas FH, Somerville J. Artificial intelligence in hospital infection prevention: an integrative review. Front Public Health. 2025;13:1547450. doi:10.3389/fpubh.2025.1547450.

Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244–253. doi:10.1038/nrmicro2537.

Quirce S, Barranco P. Cleaning agents and asthma. J Investig Allergol Clin Immunol. 2010;20(7):542–550.

Occupational Safety and Health Administration. Protecting Workers Who Use Cleaning Chemicals. Washington, DC: U.S. Department of Labor; 2012.

Rutala WA, Weber DJ. Disinfection and sterilization in health care facilities: an overview and current issues. Infect Dis Clin North Am. 2016;30(3):609–637. doi:10.1016/j.idc.2016.04.002.

Kampf G. Acquired resistance to chlorhexidine—is it time to establish an “antiseptic stewardship” initiative? J Hosp Infect. 2016;94(3):213–227. doi:10.1016/j.jhin.2016.08.018.

Boyce JM. Modern technologies for improving cleaning and disinfection of environmental surfaces in hospitals. Antimicrob Resist Infect Control. 2016;5:10. doi:10.1186/s13756-016-0111-x.

El Arab RA, Almoosa Z, Alkhunaizi M, Abuadas FH, Somerville J. Artificial intelligence in hospital infection prevention: an integrative review. Front Public Health. 2025;13:1547450. doi:10.3389/fpubh.2025.1547450.

Weber DJ, Kanamori H, Rutala WA. “No touch” technologies for environmental decontamination: focus on ultraviolet devices and hydrogen peroxide systems. Curr Opin Infect Dis. 2016;29(4):424–431. doi:10.1097/QCO.0000000000000284.

Kowalski W. Ultraviolet Germicidal Irradiation Handbook: UVGI for Air and Surface Disinfection. Berlin: Springer; 2009.

Weber DJ, Rutala WA, Anderson DJ, Chen LF, Sickbert-Bennett EE, Boyce JM. Effectiveness of ultraviolet devices and hydrogen peroxide systems for terminal room decontamination: focus on clinical trials. Am J Infect Control. 2016;44(5 Suppl)–e84. doi:10.1016/j.ajic.2015.11.015.

Laroussi M. Plasma medicine: a brief introduction. Plasma Process Polym. 2005;2(5):391–400. doi:10.1002/ppap.200400078.

Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1):76–83. doi:10.1016/j.biotechadv.2008.09.002.

Marra AR, Schweizer ML, Edmond MB. No-touch disinfection methods to decrease multidrug-resistant organism infections: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2018;39(1):20–31. doi:10.1017/ice.2017.226.

Wales AD, Davies RH. Co-selection of resistance to antibiotics, biocides and heavy metals, and its relevance to foodborne pathogens. Antibiotics (Basel). 2015;4(4):567–604. doi:10.3390/antibiotics4040567.

Jaglic Z, Cervinkova D. Genetic basis of resistance to quaternary ammonium compounds—the qac genes and their role: a review. Vet Med (Praha). 2012;57(6):275–281. doi:10.17221/6013-VETMED.

Didelot X, Walker AS, Peto TEA, Crook DW, Wilson DJ. Within-host evolution of bacterial pathogens. Nat Rev Microbiol. 2016;14(3):150–162. doi:10.1038/nrmicro.2015.13.

Gilbert JA, Stephens B. Microbiology of the built environment. Nat Rev Microbiol. 2018;16(11):661–670. doi:10.1038/s41579-018-0065-5.

Macesic N, Polubriaginof F, Tatonetti NP. Machine learning: novel bioinformatics approaches for combating antimicrobial resistance. Curr Opin Infect Dis. 2017;30(6):511–517. doi:10.1097/QCO.0000000000000406.

Kampf G. Antibiotic resistance can be enhanced in Gram-positive species by some biocidal agents used for disinfection. Antibiotics (Basel). 2019;8(1):13. doi:10.3390/antibiotics8010013.

Chen W, Yang H, Peng C, Wu T. Resolving the “health vs environment” dilemma with sustainable disinfection during the COVID-19 pandemic. Environ Sci Pollut Res Int. 2023;30(9):24737–24741. doi:10.1007/s11356-023-25167-6.

Kümmerer K. Significance of antibiotics in the environment. J Antimicrob Chemother. 2003;52(1):5–7. doi:10.1093/jac/dkg293.

Allegranzi B, Pittet D. Role of hand hygiene in healthcare-associated infection prevention. J Hosp Infect. 2009;73(4):305–315. doi:10.1016/j.jhin.2009.04.019.

Carling PC, Huang SS. Improving healthcare environmental cleaning and disinfection: current and evolving issues. Infect Control Hosp Epidemiol. 2013;34(5):507–513. doi:10.1086/670222.

Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246–251. doi:10.1016/j.jhin.2020.01.022.

Otter JA, Yezli S, Salkeld JAG, French GL. Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. Am J Infect Control. 2013;41(5 Suppl)–S11. doi:10.1016/j.ajic.2012.12.004.